| NY-ESO-1 based immunotherapy of cancer: current perspectives R Thomas, G Al-Khadairi, J Roelands, W Hendrickx, S Dermime, ... Frontiers in immunology 9, 947, 2018 | 223 | 2018 |
| Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive B Van Calster, I Vanden Bempt, M Drijkoningen, N Pochet, J Cheng, ... Breast cancer research and treatment 113 (1), 181-187, 2009 | 115 | 2009 |
| Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis W Hendrickx, I Simeone, S Anjum, Y Mokrab, F Bertucci, P Finetti, ... Oncoimmunology 6 (2), e1253654, 2017 | 114 | 2017 |
| Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist? L De Maeyer, E Van Limbergen, K De Nys, P Moerman, N Pochet, ... Journal of clinical oncology: official journal of the American Society of …, 2008 | 114 | 2008 |
| Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis J Decock, JR Long, RC Laxton, XO Shu, C Hodgkinson, W Hendrickx, ... Cancer research 67 (21), 10214-10221, 2007 | 109 | 2007 |
| Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells M Orecchioni, D Bedognetti, L Newman, C Fuoco, F Spada, W Hendrickx, ... Nature communications 8 (1), 1-14, 2017 | 105 | 2017 |
| Immunogenomic classification of colorectal cancer and therapeutic implications J Roelands, PJK Kuppen, L Vermeulen, C Maccalli, J Decock, E Wang, ... International journal of molecular sciences 18 (10), 2229, 2017 | 101 | 2017 |
| Plasma MMP1 and MMP8 expression in breast cancer: protective role of MMP8 against lymph node metastasis J Decock, W Hendrickx, U Vanleeuw, V Van Belle, S Van Huffel, ... BMC cancer 8 (1), 1-8, 2008 | 95 | 2008 |
| Relationship between age and axillary lymph node involvement in women with breast cancer H Wildiers, B Van Calster, LV van de Poll-Franse, W Hendrickx, J Røislien, ... J Clin Oncol 27 (18), 2931-2937, 2009 | 87 | 2009 |
| Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer J Decock, N Obermajer, S Vozelj, W Hendrickx, R Paridaens, J Kos The International journal of biological markers 23 (3), 161-168, 2008 | 85 | 2008 |
| Prognostic and predictive immune gene signatures in breast cancer D Bedognetti, W Hendrickx, FM Marincola, LD Miller Current opinion in oncology 27 (6), 433-444, 2015 | 72 | 2015 |
| Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune ResponsivenessImmunogenic Subtypes of Breast Cancer LD Miller, JA Chou, MA Black, J Chifman, A Alistar, T Putti, X Zhou, ... Cancer immunology research 4 (7), 600-610, 2016 | 71 | 2016 |
| Immune oncology, immune responsiveness and the theory of everything T Turan, D Kannan, M Patel, J Matthew Barnes, SG Tanlimco, R Lu, ... Journal for immunotherapy of cancer 6 (1), 1-10, 2018 | 52 | 2018 |
| Germline genetic contribution to the immune landscape of cancer RW Sayaman, M Saad, V Thorsson, D Hu, W Hendrickx, J Roelands, ... Immunity 54 (2), 367-386. e8, 2021 | 44 | 2021 |
| Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients C Maccalli, D Giannarelli, C Chiarucci, O Cutaia, G Giacobini, ... Oncoimmunology 6 (7), e1323618, 2017 | 40 | 2017 |
| Disentangling the relationship between tumor genetic programs and immune responsiveness D Bedognetti, W Hendrickx, M Ceccarelli, LD Miller, B Seliger Current Opinion in Immunology 39, 150-158, 2016 | 39 | 2016 |
| Pleiotropic functions of the tumor-and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice J Decock, W Hendrickx, S Thirkettle, A Gutiérrez-Fernández, ... Breast Cancer Research 17 (1), 1-13, 2015 | 38 | 2015 |
| Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response J Roelands, W Hendrickx, G Zoppoli, R Mall, M Saad, K Halliwill, ... Journal for immunotherapy of cancer 8 (1), 2020 | 37 | 2020 |
| Matrix metalloproteinase expression patterns in luminal A type breast carcinomas J Decock, W Hendrickx, M Drijkoningen, H Wildiers, P Neven, A Smeets, ... Disease markers 23 (3), 189-196, 2007 | 35 | 2007 |
| The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer F Bertucci, P Finetti, I Simeone, W Hendrickx, E Wang, FM Marincola, ... British Journal of Cancer 119 (11), 1383-1391, 2018 | 32 | 2018 |
Davide BedognettiSidra Medical and Research Centersidra.org의 이메일 확인됨
